EXPEDITION 3: A phase 3 Trial of Solanezumab in Mild Dementia due to Alzheimer’s Disease
AGENDA
6:15 - 6:30 p.m. Presentation by Dr. Lawrence S. Honig
6:30 - 7:15 p.m. Panel Discussion with
Lawrence S. Honig, MD, PhD, Columbia University Medical Center, New York, NY
Paul S. Aisen, MD, University of Southern California, San Diego, CA
Maria C. Carrillo, PhD, Alzheimer's Association, Chicago, IL
Bruno Vellas, MD, PhD, University Hospital of Toulouse, France
Eric R. Siemers, MD, Eli Lilly and Company, Indianapolis, IN
Lawrence S. Honig, MD, PhD, Columbia University Medical Center, New York, NY
Paul S. Aisen, MD, University of Southern California, San Diego, CA
Maria C. Carrillo, PhD, Alzheimer's Association, Chicago, IL
Bruno Vellas, MD, PhD, University Hospital of Toulouse, France
Eric R. Siemers, MD, Eli Lilly and Company, Indianapolis, IN
Thursday, December 08, 2016
6:15 PM Pacific Time